Victory Capital Management Inc. Buys 21,939 Shares of Sotera Health (NASDAQ:SHC)

Victory Capital Management Inc. increased its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 67.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,549 shares of the company's stock after acquiring an additional 21,939 shares during the quarter. Victory Capital Management Inc.'s holdings in Sotera Health were worth $746,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Blue Trust Inc. raised its stake in shares of Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after acquiring an additional 1,140 shares during the last quarter. True Wealth Design LLC purchased a new stake in Sotera Health in the 3rd quarter worth approximately $32,000. GAMMA Investing LLC lifted its holdings in Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after buying an additional 1,121 shares during the period. Oak Thistle LLC purchased a new stake in Sotera Health in the 4th quarter worth approximately $222,000. Finally, First Citizens Bank & Trust Co. grew its position in shares of Sotera Health by 16.8% in the 4th quarter. First Citizens Bank & Trust Co. now owns 16,689 shares of the company's stock worth $228,000 after buying an additional 2,402 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Stock Down 2.3 %

NASDAQ SHC traded down $0.28 during trading hours on Tuesday, reaching $11.93. 1,242,862 shares of the company's stock traded hands, compared to its average volume of 1,165,216. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The firm has a 50-day simple moving average of $12.92 and a 200 day simple moving average of $14.11. The firm has a market cap of $3.38 billion, a PE ratio of 47.72 and a beta of 1.92.

Remove Ads

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of research analyst reports. Barclays reduced their price objective on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a research report on Friday, February 28th. The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, December 6th. They set a "neutral" rating and a $14.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $15.92.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.